| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 1,223 | 1,557 | 1,762 | 2,989 | | Cost of Revenue | 674 | 1,284 | 954 | 1,587 | | | Gross Profit | 549 | 272 | 808 | 1,403 | | | Operating Expenses | | Research Development | 173 | 248 | 274 | 251 | | Selling General and Administrative | 961 | 1,139 | 1,151 | 1,420 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (585) | (1,115) | (617) | (269) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10 | 14 | 17 | (2) | | Earnings Before Interest And Taxes | (575) | (1,100) | (600) | (271) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (575) | (1,100) | (600) | (271) | | Income Tax Expense |
-
| 712 | (339) | (157) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (575) | (1,813) | (261) | (114) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (575) | (1,813) | (261) | (114) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($575) | ($1,813) | ($261) | ($114) |
|
0.03% Nasdaq 0.00%
Income Statement
